Centogene (CNTG)
(Delayed Data from NSDQ)
$0.39 USD
-0.01 (-2.26%)
Updated Jun 26, 2024 03:37 PM ET
After-Market: $0.42 +0.03 (7.69%) 6:04 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Brokerage Reports
Centogene N.V. [CNTG]
Reports for Purchase
Showing records 1 - 13 ( 13 total )
Company: Centogene N.V.
Industry: Medical Info Systems
Preliminary 2023 Revenue Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
Joint Venture Transaction Completed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
Company: Centogene N.V.
Industry: Medical Info Systems
Strategic Collaboration For Joint Venture in Saudi Arabia Inked; $30M Loan Secured
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
2022 Financial Results Reported; Reiterate Buy; Lowering PT to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
New Genetic Data Interpretation Tool Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
PCR-Free Whole Genome Sequencing Solution Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
Company: Centogene N.V.
Industry: Medical Info Systems
Observational Study in Dementia Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
Company: Centogene N.V.
Industry: Medical Info Systems
Leveraging the Largest BioDatabank for Rare Diseases; Initiating at Buy and $2.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Centogene N.V.
Industry: Medical Info Systems
Company: Centogene N.V.
Industry: Medical Info Systems
Coronavirus, Vol. 4: Public - Private Partnerships Working to Ramp up Tests
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
|